J&J pledges not to enforce TB patents in certain countries

In a move welcomed by healthcare charities, Johnson & Johnson (J&J) has confirmed that it will not enforce patents it owns and controls for Sirturo (bedaquiline) in the treatment of multidrug-resistant tuberculosis (MDR-TB) in 134 low-and middle-income countries.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

J&J accuses ex-employees of stealing trade secrets

15 December 2022 Lawsuit alleges former employees stole a “treasure trove” of confidential information from three J&J units | Complaint says defendant engaged in a systematic process of hiring Auris staff.

article

J&J awarded $18m in fake surgical devices case

27 July 2023 Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

More on this story

article

J&J awarded $18m in fake surgical devices case

27 July 2023 Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

Americas

J&J accuses ex-employees of stealing trade secrets

More on this story

article

J&J awarded $18m in fake surgical devices case

27 July 2023 Judge enters default judgment and permanent injunction order after defendant failed to show in court | Alleged counterfeit medical tools were being sold under Ethicon brand.

Americas

J&J accuses ex-employees of stealing trade secrets